Company Filing History:
Years Active: 2005
Title: The Innovations of David Harden
Introduction
David Harden is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate chemokine receptor activity. His work is essential for advancing therapies for various diseases related to chemokine receptors.
Latest Patents
David Harden holds a patent for "Substituted piperidine compounds useful as modulators of chemokine receptor activity." This invention provides compounds of a specific formula, detailing the processes for their preparation, pharmaceutical compositions containing them, and their therapeutic uses. The focus of this patent is on treating diseases and conditions related to chemokine receptor activity.
Career Highlights
Harden is associated with AstraZeneca, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on innovative solutions that address critical health challenges. His expertise in the field has led to the development of valuable therapeutic compounds.
Collaborations
David has collaborated with notable colleagues, including Stephen Thom and Andrew Baxter. These partnerships enhance the research and development efforts within his team, contributing to the advancement of their projects.
Conclusion
David Harden's contributions to the field of pharmaceutical innovation are noteworthy. His patent on substituted piperidine compounds exemplifies his commitment to improving therapeutic options for patients. His work continues to impact the medical community positively.